Zimmer Biomet Holdings (ZBH) Non-Current Debt (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Non-Current Debt came in at $6.3 billion in Q1 2026, down 4.28% year-on-year from $6.6 billion in Q1 2025, and down 9.19% quarter-over-quarter from $6.9 billion in Q4 2025.
Zimmer Biomet Holdings (ZBH) Non-Current Debt (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Non-Current Debt history runs 18 years deep, the most recent figure standing at $6.3 billion for Q1 2026.
- On a quarterly basis, Non-Current Debt fell 4.28% year-over-year to $6.3 billion in Q1 2026; TTM through Mar 2026 was $6.3 billion, a 4.28% decrease from a year earlier, with the FY2025 full-year figure at $6.9 billion, up 29.77% from the prior year.
- Non-Current Debt fell to $6.3 billion in Q1 2026 per ZBH's latest filing, from $6.9 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $7.5 billion in Q3 2025 and bottomed at $4.0 billion in Q2 2024.
- The 5-year median for Non-Current Debt is $5.2 billion (2023), against an average of $5.5 billion.
- Across the five-year window, Non-Current Debt jumped 170425.81% in 2022 and retreated 23.75% in 2024, its largest moves.
- Year by year, Non-Current Debt stood at $5.2 billion in 2022, then dropped by 5.52% to $4.9 billion in 2023, then gained by 9.73% to $5.3 billion in 2024, then increased by 29.77% to $6.9 billion in 2025, then fell by 9.19% to $6.3 billion in 2026.
- Per Business Quant, the three latest ZBH Non-Current Debt figures stand at $6.3 billion (Q1 2026), $6.9 billion (Q4 2025), and $7.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Zimmer Biomet Holdings | 18.11 Bn | 17.69 Bn | 1.51 Bn | 6.30 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.30 Bn |
| Dec 31, 2025 | 6.93 Bn |
| Sep 30, 2025 | 7.51 Bn |
| Jun 30, 2025 | 6.75 Bn |
| Mar 31, 2025 | 6.58 Bn |
| Dec 31, 2024 | 5.34 Bn |
| Sep 30, 2024 | 4.74 Bn |
| Jun 30, 2024 | 3.96 Bn |
| Mar 31, 2024 | 4.83 Bn |
| Dec 31, 2023 | 4.87 Bn |
| Sep 30, 2023 | 5.13 Bn |
| Jun 30, 2023 | 5.19 Bn |
| Mar 31, 2023 | 5.20 Bn |
| Dec 31, 2022 | 5.15 Bn |
| Sep 30, 2022 | 5.06 Bn |
| Jun 30, 2022 | 5.17 Bn |
| Mar 31, 2022 | 5.29 Bn |
| Dec 31, 2021 | 1.00 Bn |
| Sep 30, 2021 | 6.46 Bn |
| Jun 30, 2021 | 1.00 Bn |